Vestaron raises more than $20M in oversubscribed funding round to accelerate global commercialization of novel bioinsecticides
Date：Apr. 1, 2025
Print this page.
Vestaron Corporation leads the biopesticide industry with a technology platform for developing novel, environmentally benign insecticides. These products are derived from naturally occurring peptides, a patented technology licensed exclusively to Vestaron and protected by an extensive intellectual property estate. With several unique peptides under study, three products in late-stage development and multi-market segment potential for each product, Vestaron is poised to make a powerful impact on the $20 billion global insecticide market.
CEO
| Find this article at: http://www.agropages.com/CompanyDirectory/Detail-14383.htm | |
| Souce: | Agropages.com |
|---|---|
| Web: | www.agropages.com |
| Contact: | info@agropages.com |
